Family testing could help identify other at-risk family members who may require ongoing monitoring or treatment.1
Learn more
In Pursuit of Gene Therapies for Patients Living With Rare and Devastating Genetic Diseases
Get started with:
Rocket Pharma has partnered with leaders in genetic counseling and testing to create Mission: Genome with the goal of improving patient care and making genetic counseling and testing more accessible for patients with confirmed or suspected inherited cardiomyopathies, as well as their family members. Through this program, patients, their caregivers, and healthcare providers can more easily access genetic counseling and testing services.
As a result, we hope patients with rare diseases will get answers sooner, be more informed, feel supported, and be empowered to seek monitoring and treatment.
Genetic Counseling
Providing patients, caregivers, and other family members—including those who have not yet had genetic testing as well as those who have already had a positive test result—with answers and guidance through their genetic journey.
Genetic Testing
May lead to earlier diagnosis and help inform decisions around disease management. See testing provider page for inclusion/exclusion criteria.
Reference: 1. Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2020;142(25):e558-e631.